Monosacáridos

Glucose 6-phosphatase substrate

Potent and specific inhibitor of α-mannosidase I. It is active against the Golgi isoform (GMI) of the enzyme and blocks carbohydrate branch elongation from immature to complex and hybrid N-glycans. Its anti-viral activity against HIV-1 is characterized by the alteration of N-glycan pattern and shift to high-mannose glycans on viral glycoprotein gp120, resulting in decreased infectivity of newly synthesized virions.

fucosylation inhibitor

2,3,5-Tri-O-benzyl-b-D-ribofuranose is a synthetic monosaccharide that is used in the synthesis of complex carbohydrates such as glycosylation and polysaccharides. One use for this chemical is to modify the sugar moiety with methyl groups, yielding 2,3,5-tri-O-methyl b-D-ribofuranose. This modification helps prevent the sugar from being metabolized by enzymes in the body. The chemical can also be fluorinated to yield 2,3,5-trifluoro b-D-ribofuranose.

Phenyl-beta-D-thioglucuronic acid is a drug that is used to treat inflammatory diseases and autoimmune diseases. It is a basic structure that has been shown to have anti-estrogenic effects in vitro, although the mechanism of action is not well understood. Phenyl-beta-D-thioglucuronic acid can be crosslinked with proteins to form a matrix for wound healing. This drug has also been shown to be a potent inhibitor of proteases, and may inhibit other enzymes such as matrix metalloproteinases and serine proteases.

Building block for polymers synthesis, ionic liquids and chiral auxiliaries

The compound 1,7,7a-Triepialexine is an alkaloid that is found in plants of the genus Trientalis. It has been shown to have anti-inflammatory properties due to its ability to inhibit prostaglandin synthesis. The compound also has a stereoselective synthesis and a stereoselective syntheses.

Resource for the industrial synthesis of ascorbic acid alias Vitamin C

Inhibitor of alpha-glucosidase II

Methyl a-D-fucopyranoside is a monoclonal antibody that binds to the O-antigen of the polysaccharide chain. It is a synthetic trisaccharide consisting of an o-antigen, an α-linked D-fucose residue, and an α-linked galactose residue. This antibody interacts with the serologic subtypes of Group A Streptococcus, but not with other serogroups. Methyl a-D-fucopyranoside utilizes conformational epitopes and disaccharides which are not accessible to other antibodies in order to bind to the o-antigen. The o-antigen is composed of two serologically distinct regions: one region for binding by anti-A antibodies, and another for binding by anti-B antibodies.

Leucine-​derived gamma-hydroxynitrile glucoside

L-Xylonic acid-1,4-lactone is an enzyme that functions as a glycolytic enzyme. It catalyzes the conversion of D-xylose to L-xylonic acid and L-xylonic acid-1,4-lactone. This enzyme is expressed in leukemia HL60 cells and is activated by acidic conditions. L-Xylonic acid-1,4-lactone has been shown to be catabolized by the enzyme xylanase. The kinetic properties of this reaction have been studied using mass spectrometric techniques and biochemical methods. The rate of the reaction was found to be dependent on the presence of divalent cations (Mg2+ or Ca2+) or monovalent ions (Na+ or K+). L-Xylonic acid 1,4 lactone also catabolizes glucose with a similar rate constant.

Glucal is a carbohydrate that is used as a synthon in organic synthesis. It has been shown to be anomeric and can be synthesized by acetylation of the corresponding aldose, or by the glycosidic bond reaction with borohydride reduction. Glucal is not stable at high pH and can undergo ring-opening reactions with nucleophiles such as sodium borohydride. Glucal also reacts with glycoconjugates to form new molecules, which are called glycosidic products.

1,3,5-Tri-O-benzoyl-a-D-ribofuranose is a modified carbohydrate. It is synthesized by the methylation of 1,3,5-tri-O-benzoyl-a-D-arabinopyranose followed by glycosylation with 3,6-dideoxyhexose. This compound has been used as a substrate in enzymatic studies to investigate the modification of carbohydrates by glycosylation and methylation and can be used for the synthesis of other saccharides.

Isosorbide dinitrate is used to treat chronic bronchitis and congestive heart failure. It dilates blood vessels, allowing more oxygen-rich blood to reach the heart. Isosorbide dinitrate is also used to relieve chest pain (angina) and reduce complications after a heart attack. Isosorbide dinitrate is a prodrug that is converted in vivo to its active form, isosorbide mononitrate, by the enzyme nitric oxide synthase in response to hypoxia. In addition, it has been shown that this drug reduces levels of low-density lipoprotein cholesterol (LDL-C) and may be useful for the treatment of high cholesterol.
The mechanism of action for reducing LDL-C levels is not known but may be due to increased clearance of LDL-C from plasma or decreased production of very low density lipoproteins (VLDL). This medication does not affect triglycerides or high density lip